Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-04-25

Clinical Trial Update: Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating neuroinflammation and age-related brain pathology as potential mechanisms of cognitive impairment in ovarian cancer has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ovarian Cancer | Phase 1 | Status: WITHDRAWN